New data show Symbicort reduces attacks in mild asthma when used as an anti-inflammatory reliever

Alternative Medicine
AstraZenecaNew data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential anti-inflammatory reliever in mild asthma.(1) These results are published in the New England Journal of Medicine and are being presented at the American Thoracic Society 2019 International Conference.(1)

1 thought on “New data show Symbicort reduces attacks in mild asthma when used as an anti-inflammatory reliever

  1. Wonderful website you have here but I was wanting to know if
    you knew of any community forums that cover the same topics talked about here?

    I’d really love to be a part of group where I can get suggestions from other
    knowledgeable people that share the same interest.
    If you have any recommendations, please let me know. Thanks!

Leave a Reply

Your email address will not be published. Required fields are marked *